Evaluating safety reporting in paediatric antibiotic trials 2000-2016: a systematic review and meta-analysis
<p>Importance: There are very few options to treat multidrug resistant bacterial infections in children. A major barrier is the duration and complexity of regulatory trials of new antibiotics. Extrapolation of safety data from adult trials could facilitate drug development for children.</p&...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Springer Verlag
2017
|